News

Hair can be funny. Sometimes, it feels like you shaved your legs just yesterday, yet hair grows back the next day or with the ...
IGF-1R is a clinically and commercially validated target for thyroid eye disease (TED) that had US revenues of approximately $1.8 billion in 2023.
Thyroid Disease During Pregnancy Options for Management Tuija Männistö Disclosures Expert Rev Endocrinol Metab. 2013;8 (6):537-547. Five-year View ...
Dry eye continues to be a hot spot when it comes to new diagnostic and therapeutic modalities.Large established companies and small startups alike continue to develop new products and bring them ...
Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.
Krystal Biotech rises 4% after dosing begins in a phase III study of KB803 eye drops to treat rare DEB-related corneal damage.
Purpose Anaplastic thyroid cancer (ATC) is a highly lethal malignancy in which early detection of progression could allow timely treatment modifications and potentially improve outcomes. Novel ...
A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but demonstrated fast-acting healing of the ocular surface, according to a ...
A common culprit in eye disease and heart failure In recent years, evidence has emerged that ApoM can serve as a protective molecule with known anti-inflammatory effects and roles in maintaining ...
Autoimmune thyroid disease (AITD) causes cellular damage and alters thyroid gland function by humoral and cell-mediated mechanisms.